New hope for advanced skin cancer: sonidegib shows promise in chinese trial
NCT ID NCT06880848
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study tested the drug sonidegib in 160 Chinese adults with a type of advanced skin cancer called basal cell carcinoma that could not be treated with surgery or radiation. The goal was to see how well the drug shrank tumors and to check for side effects. Results showed how many patients had their tumors shrink or disappear, and how long that benefit lasted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, BASAL CELL (BCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University First Hospital
Beijing, China, 100034, China
Conditions
Explore the condition pages connected to this study.